# Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

Organization · id `cardio:org-hangzhou-zhongmei-huadong-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Hangzhou+Zhongmei+Huadong+Pharmaceutical+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 10 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus (`cardio:ct-nct06481085`)
- Sponsors: Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes (`cardio:ct-nct06739044`)
- Sponsors: A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus (`cardio:ct-nct07082114`)
- Sponsors: A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin (`cardio:ct-nct07109700`)
- Sponsors: Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease (`cardio:ct-nct07116928`)
- Sponsors: Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus (`cardio:ct-nct07193459`)
- Sponsors: Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (`cardio:ct-nct07244003`)
- Sponsors: A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (`cardio:ct-nct07394114`)
- Sponsors: A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor (`cardio:ct-nct07417306`)
- Sponsors: Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule (`cardio:ct-nct07508618`)

## Provenance

Content hash: 43c278de58eba4b3a713dd9097d38a317758d6aa393b3871c5279dafa363a920
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
